Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

Research highlights Biomarkers that would predict response to neoadjuvant chemotherapy in advanced ovarian cancer patients are eagerly needed: • Neutrophil to Lymphocyte Ratio (NLR) is an indicator of systemic inflammatory response to the malignancy. • NLR was evaluated in 132 patients undergoing Ne...

Full description

Bibliographic Details
Main Authors: M. Liontos, A. Andrikopoulou, K. Koutsoukos, C. Markellos, E. Skafida, O. Fiste, M. Kaparelou, N. Thomakos, D. Haidopoulos, A. Rodolakis, M. A. Dimopoulos, F. Zagouri
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Journal of Ovarian Research
Online Access:https://doi.org/10.1186/s13048-021-00902-0

Internet

https://doi.org/10.1186/s13048-021-00902-0

Similar Items